Cart
sales@molnova.com
MOSLOFLAVONE
CAS No. 740-33-0
MOSLOFLAVONE( —— )
Catalog No. M20486 CAS No. 740-33-0
MOSLOFLAVONE showed promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 0.71 μM and 7.8 μM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 300 | In Stock |
|
| 10MG | 511 | In Stock |
|
| 25MG | 807 | In Stock |
|
| 50MG | 1062 | In Stock |
|
| 100MG | 1467 | In Stock |
|
| 500MG | 2934 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMOSLOFLAVONE
-
NoteResearch use only, not for human use.
-
Brief DescriptionMOSLOFLAVONE showed promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 0.71 μM and 7.8 μM respectively.
-
DescriptionMOSLOFLAVONE showed promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 0.71 μM and 7.8 μM respectively.
-
In VitroMosloflavone shows promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 16.4 uM and 6.4 uM, respectively; inhibits TNF-α, IL-1β and iNOS levels in the supernatant of mouse macrophage cell line J774A as a dose-dependent manner, it also can be used as a starting point to discover lead structures for treatment of inflammatory and immunomodulatory diseases.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF-α|IL-1β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number740-33-0
-
Formula Weight298.29
-
Molecular FormulaC17H14O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (167.62 mM)
-
SMILESCOc1cc2oc(cc(=O)c2c(O)c1OC)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Singh B Sidiq T Joshi P et al. Anti-inflammatory and immunomodulatory flavones from Actinocarya tibetica Benth.[J]. Natural Product Research 2013 27(23):2227-2230.
molnova catalog
related products
-
Thalidomide
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
-
Certolizumab pegol
Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
-
Bioymifi
Bioymifi can act as a single agent to induce DR5 clustering and aggregation, leading to apoptosis
